1.COVID-19 (SARS-CoV-2) mRNA vaccination does not affect basal sex hormone levels (follicle-stimulating hormone, luteinizing hormone, estradiol) in reproductive-age women
Haeng Jun JEON ; Woo Sik LEE ; Ji Eun PARK ; Ji Young HWANG ; Ji Won KIM
Clinical and Experimental Reproductive Medicine 2024;51(2):151-157
Objective:
People vaccinated with the coronavirus disease 2019 (COVID-19) (severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2]) mRNA vaccine have reported experiencing various adverse effects. For instance, reproductive-age women have presented with complaints of abnormal uterine bleeding or menstrual cycle changes. We speculated that differences in basal sex hormone levels before and after vaccination may be present in women who experienced irregular bleeding or menstrual cycle changes; thus, this study aimed to investigate the differences in basal sex hormone levels of women before and after two doses of SARS-CoV-2 mRNA vaccination.
Methods:
This retrospective study included patients who received SARS-CoV-2 mRNA vaccines between January 2021 and February 2022 at a single center. In an outpatient setting, patients were queried regarding their menstrual cycle, the date of SARS-CoV-2 mRNA vaccination, vaccination type, and vaccination side effects. Differences in basal hormone levels (menstrual cycle days 2–3, follicle-stimulating hormone [FSH], luteinizing hormone [LH], and estradiol) before and after vaccination were compared.
Results:
Among the 326 patients, patients with no laboratory records of the hormones were excluded. The median time interval between SARS-CoV-2 mRNA vaccination and the laboratory test day was 79 days (interquartile range, 44 to 127). A comparative analysis of these hormones before and after vaccination revealed no significant differences. Subgroup analyses based on age and reported adverse events also found no statistically significant differences.
Conclusion
This study showed no significant differences in basal hormone levels (FSH, LH, and estradiol) before and after SARS-CoV-2 mRNA vaccination.
3.Efficacy and Tolerability of Moclobemide Compared with Amitriptyline in Dysthymic Disorder.
Min Soo LEE ; Jong Won NAM ; Ji Hyun CHA ; Young Ku KIM ; Seung Ho RYU
Journal of the Korean Society of Biological Psychiatry 1999;6(1):96-101
BACKGROUND: Since dysthymia begins in late childhood or adolescence and has a chronic course, long-term pharmacotherapy may be required. New generation antidepressant, moclobemide, with more acceptable side effect profiles, is effective in the treatment of dysthymia. The main objective of this study was to determine whether they exhibit comparable efficacy and tolerability in dysthymia to amitriptyline. METHOD AND MATERIALS: The efficacy and tolerability of the moclobemide and amitriptyline, were compared in a eight-week single-centre double-blind study in patients(n=37) with dysthymia using he HAMD-17, the Clinical Global Impression Scale(CGI), the Montgomery-Asberg Depression Rating Scale(MADRS), Efficacy Index-Therapeutic Index(EITE), 4-point Index Side Effect Scale(4-PISES), and Efficacy Index-Side Effect Scale(EISE). RESULTS: A total of 37 patients entered the study, 19 were randomly assigned to the moclobemide group and 18 to be amitriptyline group. Demographic and illness characteristics were similar in both groups. There were no significant difference between two groups at the total 17-HDRS score, the HAMD-17% improvement, the total MADRS score, CGI response, and the EITE. In the comparison of EISE between two groups, the scores of the moclobemide group were relatively lower than the amitriptylinen group in full treatment. And the differences were significant(moclobemide group 1.39+/-0.61 ; amitriptyline group 2.00+/-0.85, p<.001). At the 4-PISE. There was no serious or treatment threatening side effects. And there was no specific difference in side effects between two groups. The moclobemide group reported higher EIR scores than the amitriptyline group at every follow up day, but the differences were not significant. And there was no significant differences in the scores of five HRQOL subcategories which is compared between two groups at every follow up days. CONCLUSIONS: In terms of 17-HDRS and MADRS, moclobemide and amitriptyline are equally effective at least in allevating dysthymic symptoms. But moclobemide tended to be less troubling and better tolerated than amitriptyline. Therefore, moclobemide treatment can be used as a safe, and higher satisfactory treatment strategy for the dysthymia.
Adolescent
;
Amitriptyline*
;
Depression
;
Double-Blind Method
;
Drug Therapy
;
Dysthymic Disorder*
;
Follow-Up Studies
;
Humans
;
Moclobemide*
4.Concomitant Ipsilateral Femur Neck Fracture Associated with Comminuted Femur Shaft Fracture: Clinical Review of Four Cases
Seung Gyun CHA ; Won Suck RHI ; Jong In KIM ; Ji Sun PARK ; Ki Young KIM
The Journal of the Korean Orthopaedic Association 1990;25(6):1674-1680
Ipsilateral fractures of the femur neck and shaft show diagnostic difficulties and complexity of the treatment. This femoral double fracture, when not initially diagnosed, carries a much high risk of complications, such as aseptic necrosis of the femoral head. Early recognition is of importance. The definitive treatment of a fractured femur should be begun after the ipsilateral hip and the knee joint have been examined clinically and radiologically. At the Department of Orthopedic Surgery, Dae Han General Hospital, from July 1985 to March 1990, four cases of the concomitant ipsilateral femur neck and shaft fracture had been treated and followed-up for 2.4 years in average (ranging from 1.1 to 4.7 years).
Femoral Neck Fractures
;
Femur Neck
;
Femur
;
Head
;
Hip
;
Hospitals, General
;
Knee Joint
;
Necrosis
;
Orthopedics
5.Pregnancy after Isolated Sleeve Gastrectomy in Morbidly Obese Patient.
Sang Moon HAN ; Ji Hyun OH ; Ji Hyeon PARK ; Won Woo KIM
Journal of the Korean Surgical Society 2006;70(4):325-328
Bariatric surgery is the best known procedure for treating severe obesity and the majority of patients who received surgical weight loss procedure were at childbearing age. Female patients who successfully lost weight following bariatric procedure, become pregnant and those are need to be evaluated carefully due to various operative procedures and to ensure intake of quality nutrition. A 35-year-old female, gravida 4, para 2, treated for morbid obesity with vertical sleeve gastrectomy performed 14 months earlier, presented 7 weeks of gestation. Before surgery, she had weighed 92.4 kg (body mass index (BMI); 32.9 kg/m(2)); she had gradually reduced her weight to 65.5 kg (BMI; 23.5 kg/m(2)) postoperatively at 14 months. For the first trimester of pregnancy, her average intake was 698.6 kcal/day from food, and 840~1352.8 kcal/day in second and third trimester. During pregnancy, significant iron, cobalamin and vitamin B12 deficiencies were not founded. She has gained a total of 8 kg. She delivered a healthy female infant at full term. Nutritional supplementation following bariatric surgery and close supervision during pregnancy can prevent nutrition-related complications and improve maternal and fetal health.
Adult
;
Bariatric Surgery
;
Female
;
Gastrectomy*
;
Humans
;
Infant
;
Iron
;
Obesity, Morbid
;
Organization and Administration
;
Pregnancy Trimester, First
;
Pregnancy Trimester, Third
;
Pregnancy*
;
Surgical Procedures, Operative
;
Vitamin B 12
;
Vitamin B 12 Deficiency
;
Weight Loss
6.What is the best treatment of heterotopic cervical pregnancies for a successful pregnancy outcome?.
Ji Won KIM ; Han Moie PARK ; Woo Sik LEE ; Tae Ki YOON
Clinical and Experimental Reproductive Medicine 2012;39(4):187-192
Heterotopic pregnancy is rare event and the risk is increased with assisted reproductive technology procedures. Heterotopic cervical pregnancy is even more unusual. We report a rare case of heterotopic cervical pregnancy that was managed successfully. A 36-year-old women who conceived by IVF-ICSI was diagnosed with heterotopic cervical pregnancy. She visited the emergency room with vaginal bleeding at 5 weeks of gestation and underwent careful intracervical gestational sac reduction with forceps under abdominal guidance the next day. The postoperative course was uneventful and with regular check-ups, the intrauterine pregnancy (IUP) progressed unremarkably through 41 weeks with delivery of a healthy newborn. We reviewed a total of 37 cases of heterotopic pregnancy that have been reported in the English language literature. There have been many attempts to eliminate the cervical embryo while preserving the IUP, and complete cervical evacuation is important in order to avoid infection, bleeding, and premature birth.
Embryonic Structures
;
Emergencies
;
Female
;
Gestational Sac
;
Hemorrhage
;
Humans
;
Infant, Newborn
;
Pregnancy
;
Pregnancy, Heterotopic
;
Premature Birth
;
Reproductive Techniques, Assisted
;
Surgical Instruments
;
Uterine Hemorrhage
7.Hysteroscopic Septotomy of a Complete Septate Uterus Using a Balloon with Methylene Blue
Ji Hyon JANG ; Jung Hyun CHO ; Dong Hyun CHA ; Won Bo HAN
Korean Journal of Fertility and Sterility 2010;37(4):369-375
A complete septate uterus with cervical duplication and a longitudinal vaginal septum is a rare uterine malformation. The dissection of the septum can be difficult because it is difficult for hysteroscopists to find out initial point, direction and final point of a complete septum. This study aimed the introduction of more efficient surgical procedure using a balloon with methylene blue. We have experienced three cases with a complete septate uterus. We performed hysteroscopic dissection of a complete uterine septum using a balloon with methylene blue and obtained good reproductive outcomes. So we report three cases with a brief review of literatures.
Methylene Blue
;
Uterus
8.New-onset Refractory Status Epilepticus after BNT162b2 mRNA COVID-19 Vaccination
Hyun Kyung KIM ; Ye Ji JANG ; Taeho SEO ; Yoo Jeong ROH ; Jung-Won SHIN
Journal of the Korean Neurological Association 2023;41(3):204-209
Increasing importance of vaccination during coronavirus disease 2019 (COVID-19) pandemic, several vaccines were developed. Messenger RNA (mRNA) vaccines including BNT162b2 (Pfizer, New York, NY, USA; BioNTech, Mainz, Germany), mRNA-1273 (Moderna, Cambridge, MA, USA) have been disclosed side effects such as thrombocytopenia, myocarditis and headache in general. In addition, adverse effects due to autoimmune responses induced by spike glycoproteins of mRNA vaccines are rarely reported such as the Guillain-Barre syndrome, autoimmune encephalitis and so on. Herein, we report a rare case of encephalitis with new-onset refractory status epilepticus after BNT162b2 mRNA COVID-19 vaccination improved with immune therapy.
9.Factors Affecting the Severity of Depressive Symptoms in the Elderly.
Min Soo LEE ; Jong Won NAM ; Ji Hyun CHA ; Dong Ill KWAK
Journal of Korean Neuropsychiatric Association 1999;38(5):1063-1070
The depressive symptoms are frequent and important ones in the elderly population. We studied the various factors affecting the severity of depressive symptoms in the elderly population. The Korean elderly (more than 65 years old; n=490) in Seoul area (city) were studied on the identifying data and medical and psychiatric history, Mini-Mental State Examination (MMSE) Geriatric Depression Scale (GDS) Korean Depression Scale(KDS: under development)were also administered. In our study, the significant effect of sex, age, education, marital status, and the status of medical security on the severity of depressive symptoms were not found. Significantly higher GDS and KDS scores were found in the elderly who have more than one physical illness, subjective memory complaints, and seven life events. To examine the strength of association of these variables of depression, we conducted logistic regression. Depressive symptoms were associated with 1)the loss of spouse, 2)a current physical illness, and 3)low socioeconomic status. These results showed that depression in the elderly may be correlated with the loss of spouse, a current physical illness, and low socioeconomic status.
Aged*
;
Depression*
;
Education
;
Humans
;
Logistic Models
;
Marital Status
;
Memory
;
Seoul
;
Social Class
;
Spouses
10.A Clinical Study of Malignant Tumors of the Maxilla.
Ji Young BAEK ; Sung Won CHOI ; Eui Woong LEE ; Eun Chang CHOI ; In Ho CHA
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2000;26(4):391-395
Malignant tumors of the maxilla represent about 3-4% of head and neck malignant neoplasm and the origins are maxillary gingiva, hard palate and maxillary sinus. We are to investigate clinical features and results according to various treatment modalities of maxillary malignant tumor to get information for better treatment results. Sixty patients with malignant maxillary tumors treated at Yonsei medical center from 1992 to 1997 were studied retrospectively. They are evaluated according to clinical signs & symptoms, stages at first diagnosis, primary site, histopathologic features, treatment method, recurrence and survival rate with clinical records, biopsy results and CT radiograph. The most common primary site was maxillary sinus and most common histopathology was squamous cell carcinoma. The local recurrence rate was 18% at 5 years, neck failure was 3% and distant metastasis was 18%. Overall survival rate was 78% at 2 years and 69% at 5 years. Failure at primary site is the main problem in the curative treatment. So, to improve survival in these patients efforts should be directed toward improvement of local control.
Biopsy
;
Carcinoma, Squamous Cell
;
Diagnosis
;
Gingiva
;
Head
;
Humans
;
Maxilla*
;
Maxillary Sinus
;
Neck
;
Neoplasm Metastasis
;
Palate, Hard
;
Recurrence
;
Retrospective Studies
;
Survival Rate